Kazuko Tajiri

ORCID: 0000-0002-9759-1008
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Viral Infections and Immunology Research
  • Cancer Immunotherapy and Biomarkers
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Fibrosis and Remodeling
  • Cardiac Imaging and Diagnostics
  • CAR-T cell therapy research
  • Cardiac Arrhythmias and Treatments
  • Cell Adhesion Molecules Research
  • Cardiovascular Effects of Exercise
  • Cardiac tumors and thrombi
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Peptidase Inhibition and Analysis
  • Cardiovascular Function and Risk Factors
  • Cytokine Signaling Pathways and Interactions
  • Atherosclerosis and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Melanoma and MAPK Pathways
  • Cardiac Structural Anomalies and Repair
  • Pericarditis and Cardiac Tamponade
  • Cardiac Valve Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Myocardial Infarction Research
  • Renal and Vascular Pathologies

University of Tsukuba
2016-2025

National Cancer Center Hospital East
2022-2025

National Institute of Biomedical Innovation, Health and Nutrition
2012-2021

Vanderbilt University Medical Center
2021

Pitié-Salpêtrière Hospital
2021

Sorbonne Université
2021

Ipsen (France)
2021

Janssen (Switzerland)
2021

Montreal Heart Institute
2019-2020

Université de Montréal
2019

Charlotte Fenioux Baptiste Abbar Samia Boussouar Marie Bretagne John R. Power and 95 more Javid J. Moslehi Paul Gougis Damien Amelin Agnès Dechartres Lorenz Lehmann Pierre‐Yves Courand Jennifer Cautela Joachim Alexandre Adrien Procureur Antoine Rozes Sarah Léonard-Louis Juan Qin Nausheen Akhter Nazanin Aghel Kingsley Amidi Élizabeth Anderson Dimitri Arangalage Mandar A. Aras Aarti Asnani Lauren A. Baldassarre Rocio Barovila Ana Sofia Barroso Wendy Bottinor Anissa Bouali Eve Cariou Wei‐Ting Chang Richard K. Cheng Shanthini M. Crusz Anita Deswal Pierre‐Yves Dietrich Grace K. Dy Clémence Docq Steven M. Ewer Suran L. Fernando Danette L. Flint Roberta Florido Satoshi Fukushima Elena Galli Elizabeth Gaughan Manhal Habib Andrew Haydon Lucie Heinzerling Osnat Itzhaki Ben Zadok N. Issa Anja Karlstaedt Kazuo Kitagawa Michael Layoun Michal Laufer‐Perl Carrie Lenneman Darryl P. Leong Chloé Lesiuk Joshua Levenson Teresa López‐Fernández Yan Liu Kristen Machado Pedro Moliner Ryota Morimoto Michel Obéid Anna Narezkina Nicolas L. Palaskas Giovanni Peretto Nicolas Piriou Juan Carlos Plana Peter P. Rainer Maxime Robert‐Halabi Fanny Rocher Eugenia Rota François Roubille Theresa Ruf Shahneen Sandhu Francis Sanjeev Nobuhiko Seki Kazuko Tajiri Yuichi Tamura Franck Thuny Romain Trésorier Isik Turker Ellen Warner Vlad G. Zaha Han Zhu Rémi Cheynier Bénédicte Charmeteau-De Muylder Alban Redheuil Florence Tubach Jacquès Cadranel Audrey Milon Stéphane Éderhy Thomas Similowski Douglas B. Johnson Ian Pizzo Toniemarie Catalan Olivier Benveniste Salim S. Hayek Yves Allenbach Michèlle Rosenzwajg

10.1038/s41591-023-02591-2 article EN Nature Medicine 2023-10-26

Rev-erb α, known as nuclear receptor 1D1 (NR1D1), regulates circadian rhythm, modulates glucose and lipid metabolism, inflammatory response. However, little is about the effect of agonist on progression myocardial infarction (MI) heart failure. To investigate it, wild-type male mice underwent sham-operation or permanent ligation left anterior descending coronary artery to create MI model. SR9009 (100 mg/kg/day) vehicle was intraperitoneally administered. Echocardiography performed evaluate...

10.1371/journal.pone.0189330 article EN cc-by PLoS ONE 2017-12-12

Tenascin-C (TN-C), an extracellular matrix glycoprotein, appears at several important steps of cardiac development in the embryo, but is sparse normal adult heart. TN-C re-expresses under pathological conditions including myocarditis, and closely associated with tissue injury inflammation both experimental clinical settings. However, pathophysiological role myocarditis not clear. We examined how affects initiation autoimmune immunologically.A model was established BALB/c mice by immunization...

10.1161/jaha.114.001052 article EN cc-by-nc-nd Journal of the American Heart Association 2014-11-07

In the present study, we aimed to investigate whether early cardiac biomarker alterations and echocardiographic parameters, including left atrial (LA) strain, can predict anthracycline-induced cardiotoxicity (AIC) thus develop a predictive risk score.

10.1253/circj.cj-24-0065 article EN Circulation Journal 2024-03-07

Abstract Aims Tenascin-C (TN-C) is an extracellular matrix protein undetected in the normal adult heart, but expressed several heart diseases associated with inflammation. We previously reported that serum TN-C levels of myocardial infarction (MI) patients were elevated during acute stage, and high peak at risk left ventricular (LV) remodelling poor outcome, suggesting could play a significant role progression remodelling. However, detailed molecular mechanisms this process remain unknown....

10.1093/cvr/cvy244 article EN Cardiovascular Research 2018-10-05

Neutrophils are recruited into the heart at an early stage following a myocardial infarction (MI). These secrete several proteases, one of them being neutrophil elastase (NE), which promotes inflammatory responses in disease models. It has been shown that there is increase NE activity patients with MI; however, role MI remains unclear. Therefore, present study aimed to investigate pathogenesis mice. expression peaked on day 1 infarcted hearts. In addition, deficiency improved survival and...

10.3390/ijms22020722 article EN International Journal of Molecular Sciences 2021-01-13

10.1016/j.ejca.2022.07.018 article EN publisher-specific-oa European Journal of Cancer 2022-08-24

Myocarditis and subsequent dilated cardiomyopathy are major causes of heart failure in young adults. humans is highly heterogeneous etiology. Recent studies have indicated that a subgroup myocarditis patients may benefit from immune-targeted therapies, because autoimmunity plays an important role as well contributing to the progression failure. Suppressor cytokine signaling (SOCS) 1 key negative regulation both TLR- receptor-mediated signaling, which involved innate immunity adaptive...

10.4049/jimmunol.1103610 article EN The Journal of Immunology 2012-07-15

A 70-year-old man with esophageal cancer undergoing nivolumab treatment presented to our hospital suspected myocarditis associated immune checkpoint inhibitor (ICI) therapy. The initial echocardiographic assessment upon admission demonstrated a preserved left ventricular (LV) ejection fraction but impaired right (RV) function. An endomyocardial biopsy revealed significant lymphocytic infiltration and myocyte necrosis. High-dose steroid therapy was initiated on the day of admission. However,...

10.1536/ihj.24-701 article EN International Heart Journal 2025-01-01

Background Both endocardial trigger elimination and epicardial substrate modification are effective in treating ventricular fibrillation (VF) Brugada syndrome. However, the primary approach characteristics of patients who respond to ablation remain unknown. Methods Among 123 symptomatic syndrome (VF, 63%; syncope, 37%), was performed 21 VF/electrical storm patients, majority whom were resistant antiarrhythmic drugs. Results Careful mapping revealed that 81% had no specific findings, whereas...

10.1161/circep.117.005631 article EN Circulation Arrhythmia and Electrophysiology 2018-08-01

Background There is growing evidence indicating a close relationship between inflammation and atrial fibrillation (AF). Although underlying inflammatory cardiomyopathy may contribute to the development of AF, arrhythmogenic remodeling caused by has not been elucidated in detail. Herein, we examined electrical, structural, autonomic changes atria mouse model autoimmune myocarditis. Methods BALB/c mice were immunized with cardiac myosin peptide (MyHC-α 614–629 ) conjugated complete Freund’s...

10.3389/fcvm.2022.1075358 article EN cc-by Frontiers in Cardiovascular Medicine 2023-01-19
Coming Soon ...